Table 1

Clinicopathological variables according to c-erbB2 status

HER-2-negative

HER-2-positive

P

Overall

Total

54

13

67

Oestrogen receptor status

≤ 10 fmol/mg

25

10

0.05*

35

> 10 fmol/mg

29

3

32

Node status

Negative

36

8

0.73

44

Positive

18

5

23

Histologic grade

Grade I

4

0

0.48

4

Grade II

17

5

22

Grade III

22

7

29

'Other'

11

1

12

Nottingham Prognostic Index

GPG score ≤ 3.4

4

1

0.61

6

MPG score 3.4–5.4

28

8

40

PPG score > 5.4

7

3

10

Age

< 50 years

19

8

28

≥ 50 years

35

5

39

Median (range)

56 (32–80)

46 (37–67)

0.03*

55 (32–80)

Tumour size

≤ 2 cm

15

4

19

> 2 cm

39

9

48

Median (range)

2.5 (1–5.5)

2.6 (1–5.3)

0.76

2.5 (1–5.5)

GPG, good prognostic group; MPG, moderate prognostic group; PPG, poor prognostic group. *Relationship reached significance (P ≤ 0.05).

Winters et al. Breast Cancer Res 2003 5:R242   doi:10.1186/bcr654